Tesamorelin 2 mg
- Active Substance: Tesamorelin
- Concentration: 2 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Tesamorelin
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.89 g/mol
- Sequence: H-His-D-Trp-Ala-Trp-D-Phe-Lys-Thr-Phe-Thr-Ser-Tyr-Ser-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Synonyms: Egrifta, Growth Hormone-Releasing Factor (GHRF) Analog
Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), designed to increase the body's natural production of growth hormone. Supplied as a 2 mg injectable vial by Peptide Sciences USA, it is primarily researched for its impact on visceral adipose tissue reduction and metabolic health, particularly in lipodystrophy and aging models.
Mechanism of Action
Tesamorelin functions by binding to GHRH receptors in the anterior pituitary, stimulating the release of endogenous growth hormone (GH). This cascade influences downstream production of insulin-like growth factor 1 (IGF-1), which is responsible for many of GH's anabolic and metabolic effects. Elevated GH and IGF-1 levels enhance lipolysis, reduce visceral fat accumulation, and support lean muscle preservation.
Preclinical studies have shown that Tesamorelin effectively decreases abdominal fat without significantly altering subcutaneous fat or lean body mass. Its long-acting structure allows for more sustained GH stimulation compared to endogenous GHRH, making it valuable in metabolic and fat reduction research settings. It may also improve markers related to insulin sensitivity, triglycerides, and inflammatory biomarkers in relevant models.
Key Features & Benefits
- Stimulates Natural GH Secretion: Mimics GHRH to increase growth hormone levels safely and effectively.
- Visceral Fat Reduction: Promotes targeted loss of abdominal fat with minimal impact on lean tissue.
- Long-Lasting Effect: Engineered for a longer half-life and greater biological availability than native GHRH.
- Supports Metabolic Health: Studied for benefits in insulin sensitivity, lipid metabolism, and inflammation markers.
- Research-Grade Purity: Manufactured in the USA under controlled conditions for scientific reliability.
Legal Disclaimer
Disclaimer: Tesamorelin is supplied strictly for laboratory and scientific research. It is not intended for human consumption, therapeutic use, or cosmetic application. Use must comply with all relevant safety and regulatory standards.
Frequently Asked Questions
Tesamorelin stimulates the pituitary gland to release growth hormone, which in turn promotes lipolysis, reduces visceral fat, and supports metabolic balance.
Tesamorelin is not banned. However, it is a controlled research substance not approved for over-the-counter use. Its use is restricted to medical or scientific research purposes.
In research settings, Tesamorelin is associated with targeted fat loss, particularly visceral abdominal fat, but it may not significantly affect overall body weight.
Tesamorelin is legal for licensed scientific research but is not approved for general public use without proper authorization. It is FDA-approved for specific medical conditions but not as a supplement.
Related Products
- Active Substance: Tesamorelin
- Concentration: 5 mg per vial
- Pack Size: Lyophilized injectable vial
- Manufacturer: Dragon Pharma
- Brand Name: Tesamorelin
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.91 g/mol
- Synonyms: Egrifta, GHRH(1–44) analog, GHRH modulator
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)